Skip to main content
. 2017 May 4;8(35):59986–59990. doi: 10.18632/oncotarget.17607

Figure 1.

Figure 1

Thoracic CT scan of primary lesion (A) at baseline and (B) after 60 day of treatment with Afatinib. (C) Adrenal metastasis at baseline (D) and response to treatment after 60 days.